Overview
A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors.
Indication
Used as adjunctive therapy for the treatment of peptic ulcer. Also used to treat nausea and vomiting due to motion sickness.
Associated Conditions
- Peptic Ulcer
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2005/09/12 | Phase 2 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| BAYSHORE PHARMACEUTICALS LLC | 76385-101 | ORAL | 5 mg in 1 1 | 4/11/2019 | |
| BAYSHORE PHARMACEUTICALS LLC | 76385-100 | ORAL | 2.5 mg in 1 1 | 4/11/2019 | |
| Breckenridge Pharmaceutical, Inc. | 51991-192 | ORAL | 5 mg in 1 1 | 1/10/2024 | |
| Aarkish Pharmaceuticals NJ Inc. | 81005-127 | ORAL | 2.5 mg in 1 1 | 2/26/2024 | |
| PD-Rx Pharmaceuticals, Inc. | 43063-740 | ORAL | 2.5 mg in 1 1 | 9/27/2023 | |
| PD-Rx Pharmaceuticals, Inc. | 43063-741 | ORAL | 5 mg in 1 1 | 9/27/2023 | |
| Breckenridge Pharmaceutical, Inc. | 51991-191 | ORAL | 2.5 mg in 1 1 | 1/10/2024 | |
| PharmaDerm a division of Fougera Pharmaceuticals Inc. | 10337-062 | ORAL | 5 mg in 1 1 | 8/9/2012 | |
| AACE Pharmaceuticals, Inc. | 71406-127 | ORAL | 5 mg in 1 1 | 2/5/2024 | |
| AACE Pharmaceuticals, Inc. | 71406-126 | ORAL | 2.5 mg in 1 1 | 2/5/2024 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| U-METAMINE TAB 1MG | N/A | synco (h.k.) limited | N/A | N/A | 3/13/1990 |
| SCOPOLAMINE SYRUP 1MG/5ML | N/A | N/A | N/A | 6/5/1987 | |
| HYOSCINE METHOBROMIDE SYR 1MG/5ML | N/A | N/A | N/A | 1/24/1992 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.